Savara Inc. YB4P.F Stock
3.52 EUR
{{ price }}
0.000000%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
489.29M EUR
LOW - HIGH [24H]
3.52
-
3.52 EUR
VOLUME [24H]
800 EUR
{{ volume }}
P/E Ratio
0
Earnings per share
-0.34 EUR
Savara Inc. Price Chart
Savara Inc. YB4P.F Financial and Trading Overview
| Savara Inc. stock price | 3.52 EUR |
| Previous Close | 2.92 EUR |
| Open | 2.88 EUR |
| Bid | 2.88 EUR x N/A |
| Ask | 2.94 EUR x N/A |
| Day's Range | 2.88 - 2.88 EUR |
| 52 Week Range | 1.08 - 2.98 EUR |
| Volume | 100 EUR |
| Avg. Volume | 1 EUR |
| Market Cap | 331.42M EUR |
| Beta (5Y Monthly) | 0.836971 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.34 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4 EUR |
YB4P.F Valuation Measures
| Enterprise Value | 246.59M EUR |
| Trailing P/E | N/A |
| Forward P/E | -8.470589 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.3449478 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -5.921 |
Trading Information
Savara Inc. Stock Price History
| Beta (5Y Monthly) | 0.836971 |
| 52-Week Change | 134.54% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.98 EUR |
| 52 Week Low | 1.08 EUR |
| 50-Day Moving Average | 1.98 EUR |
| 200-Day Moving Average | 1.73 EUR |
YB4P.F Share Statistics
| Avg. Volume (3 month) | 1 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 114.07M |
| Float | 44.54M |
| Short Ratio | N/A |
| % Held by Insiders | 1.93% |
| % Held by Institutions | 70.66% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 0.014286:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -17.62% |
| Return on Equity (ttm) | -34.42% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -41646000 EUR |
| Net Income Avi to Common (ttm) | -40407000 EUR |
| Diluted EPS (ttm) | -0.26 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 115.02M EUR |
| Total Cash Per Share (mrq) | 1.01 EUR |
| Total Debt (mrq) | 26.25M EUR |
| Total Debt/Equity (mrq) | 26.71 EUR |
| Current Ratio (mrq) | 23.898 |
| Book Value Per Share (mrq) | 0.861 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -38155000 EUR |
| Levered Free Cash Flow (ttm) | -22357124 EUR |
Profile of Savara Inc.
| Country | Germany |
| State | TX |
| City | Austin |
| Address | Building III |
| ZIP | 78746 |
| Phone | 512 614 1848 |
| Website | https://www.savarapharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 28 |
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. is headquartered in Austin, Texas.
Q&A For Savara Inc. Stock
What is a current YB4P.F stock price?
Savara Inc. YB4P.F stock price today per share is 3.52 EUR.
How to purchase Savara Inc. stock?
You can buy YB4P.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Savara Inc.?
The stock symbol or ticker of Savara Inc. is YB4P.F.
Which industry does the Savara Inc. company belong to?
The Savara Inc. industry is Biotechnology.
How many shares does Savara Inc. have in circulation?
The max supply of Savara Inc. shares is 139M.
What is Savara Inc. Price to Earnings Ratio (PE Ratio)?
Savara Inc. PE Ratio is now.
What was Savara Inc. earnings per share over the trailing 12 months (TTM)?
Savara Inc. EPS is -0.34 EUR over the trailing 12 months.
Which sector does the Savara Inc. company belong to?
The Savara Inc. sector is Healthcare.